Sparta Science Raises $16M Series B Round to Define the Movement Vital Sign and Reimagine Musculoskeletal Diagnostic Health Processes

Business Wire

GSR Ventures U.S. led the round, joined by Arsenal Growth and existing investors

MENLO PARK, Calif.--(BUSINESS WIRE)-- Sparta Science, the Silicon Valley company that applies data and technology in pursuit of human resilience, today announced a $16 million Series B funding round led by GSR Ventures U.S., a private investment firm primarily focused on early-stage companies in the United States developing AI-enabled healthcare technology, enterprise software, and consumer platforms. Arsenal Growth, the only firm to have managed investment funds for the United States Army and for the United States Treasury Department, also joined the round alongside existing investors, bringing the total capital raised to date to approximately $26 million.

The Sparta Science musculoskeletal health assessment tool is trusted by hundreds of clients, including collegiate and professional sports teams, personal health organizations, and government and military organizations. The new capital will be used to expand the company’s data science and engineering teams, further research, and accelerate the deployment of the Sparta System globally, to include health systems, hospital networks, and corporations focused on improving the personal health of their employees.

“As the healthcare industry continues its digital transformation and places a major focus on movement as a vital sign, Sparta Science is well-positioned to effectively answer the call,” said Dr. Phil Wagner, Founder and CEO, Sparta Science. “We’re thankful to our new partners at GSR Ventures U.S. and Arsenal Growth who also believe that a validated, deep awareness of musculoskeletal health is crucial to overall health assessments. Our two-million-plus Sparta Scans provide a foundation for a better understanding of the human body, its resilience and true potential.”

“We are excited to join Dr. Wagner and the team at Sparta Science which is helping redefine the future of musculoskeletal health,” added Dr. Richard Lim, Managing Partner, GSR Ventures U.S. “With an expansive track record of success in many practice areas - including sport, military and government - we see tremendous potential for The Sparta Scan to become an essential and routine diagnostic test in health systems everywhere.”

Along with GSR Ventures U.S., the strategic investment from Arsenal Growth will help Sparta Science expand its efforts in health and public sectors given the firm’s extensive experience working with government, to include the Department of Defense, Veterans Health Administration, and more.

The Sparta Science system utilizes data and machine learning software to optimize health and performance for individuals. Using evidence-based movement assessments and data-driven exercise prescriptions, the system is proven to increase resilience, minimize injury risk and speed efficient rehabilitation to physical activity. Sparta's international client roster spans healthcare and rehabilitation, professional and collegiate sports, and the military, including partners such as the Cleveland Cavaliers, Washington Redskins, Pittsburgh Steelers, Colorado Rockies, Portland Timbers, Clemson, The Ohio State University, Auburn University, The University of Texas, Oklahoma University, UCLA, University of Pennsylvania, EXOS, NYU Orthopedics, Stanford Orthopedics, the Novant Health System and many more.

About Sparta Science

Sparta Science is a Silicon Valley technology company that uses data and machine learning software to optimize health and performance for athletes, warfighters, employees and patients with evidence-based movement scans and data-driven exercise prescriptions that increase resilience, minimize injury risk and speed efficient rehabilitation to physical activity. Sparta technology is used worldwide by elite and conventional military forces, professional, collegiate, high school sports organizations, strength training professionals and medical providers committed to helping people move better, at work, at play, and on duty.

About GSR Ventures U.S.

GSR Ventures U.S., based in Palo Alto, California, primarily focuses on early-stage technology companies in the United States developing AI-enabled healthcare technology, enterprise software, and consumer platforms. Investments include Datavisor, Deep 6, and PlusAI.